ArticleFrontiers in pediatrics2022

Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis.

Zhaoling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.